- Home
- / Benitec Biopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Benitec Biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$10.7
2024-10-28
Market Capitalization
$192 M
2024-10-28
Revenue
$75 K
FY, 2023
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 102.0K | 59.0K | 73.0K | 75.0K | ||
| General and administrative expense | 5.6M | 6.5M | 6.6M | 6.4M | 7.0M | 23.4M |
| Operating expense total | 8.6M | 17.9M | 19.2M | 22.6M | 41.8M | |
| EBIT | (8.3M) | (13.6M) | (17.9M) | (19.1M) | (22.5M) | (41.8M) |
| EBIT margin, % | -8118.6% | -24457.5% | -25441.3% | |||
| Interest expense | 62.0K | (6.0K) | (32.0K) | 33.0K | 904.0K | 3.3M |
| Pre tax profit | (299.0K) | (7.9M) | (17.4M) | (19.0M) | (21.0M) | (37.2M) |
| Net Income | (8.3M) | (13.4M) | (18.2M) | (19.6M) | (21.8M) | (37.9M) |
| EPS | (14.1) | (5.5) | (1.0) |